Show simple item record

contributor authorBahmani, Fatemeh
contributor authorPearce, Daniel
contributor authorSouthern, Kaitlin
contributor authorNwadiaro, Kenechukwu
contributor authorMaddipati, Veeranna
contributor authorGeorge, Stephanie M.
date accessioned2026-08-23T08:15:25Z
date available2026-08-23T08:15:25Z
date copyright2026/02/01
date issued2026
identifier issn0148-0731
identifier otherbio-25-1235.pdf
identifier urihttp://yetl.yabesh.ir/yetl1/handle/yetl/4316287
description abstractAbstract. Pulmonary hypertension (PH) is a serious condition affecting patients with end-stage renal disease (ESRD), yet the hemodynamic mechanisms underlying development remain poorly understood. Novel alternative methods (NAMs), such as computational fluid dynamics (CFD), provide a powerful and ethical approach to investigate vascular physiology using patient-specific data. We developed a CFD model of the pulmonary artery (PA) informed by noninvasive magnetic resonance imaging (MRI) from an ESRD patient to characterize flow dynamics and wall shear metrics relevant to PH. Simulations were performed using image-based geometry, and velocity fields, wall shear stress (WSS), time-averaged wall shear stress (TAWSS), and oscillatory shear index (OSI) were quantified. Results demonstrated physiologically consistent flow distributions, with higher velocities localized near outlet regions and lower velocities in branches. Spatially averaged TAWSS was approximately 9 dyn/cm2, in agreement with previously reported ranges. OSI values were low across the pulmonary vasculature, suggesting limited flow reversal. Together, these results highlight the feasibility of using patient-specific CFD to capture PA hemodynamics in ESRD and demonstrate consistency with published physiological values. This framework demonstrates the utility of NAMs to provide insight into complex biomechanical systems and a foundation for future studies seeking to clarify mechanistic links between ESRD development, arteriovenous fistula (AVF) creation, and eventual PH development, ultimately informing development of patient-specific diagnostic and therapeutic strategies. As NAMs gain regulatory and scientific traction, approaches like this will play an important role in reducing reliance on animal models while enabling ethically responsible, patient-specific discovery in cardiovascular research.
publisherThe American Society of Mechanical Engineers (ASME)
titleFluid Flow Analysis of Pulmonary Hypertension in End-Stage Renal Disease: A Novel Alternative Methods-Driven Case Study
typeJournal Paper
journal volume148
journal issue2
journal titleJournal of Biomechanical Engineering
identifier doi10.1115/1.4070760
treeJournal of Biomechanical Engineering:;2026:;volume( 148 ):;issue:002
contenttypeFulltext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record